JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marinò, M.
Right arrow Articles by Andrews, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marinò, M.
Right arrow Articles by Andrews, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 43, 30377-30386, October 22, 1999

Identification of a Heparin-binding Region of Rat Thyroglobulin Involved in Megalin Binding

Michele Marinò, Joel A. Friedlander, Robert T. McCluskey, and David Andrews

From the Pathology Research Laboratory. Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129

We recently showed that thyroglobulin (Tg) is a heparin-binding protein and that heparin inhibits binding of Tg to its endocytic receptor megalin (gp330). Here we have identified a heparin-binding region in the carboxyl-terminal portion of rat Tg and have studied its involvement in megalin binding. Rat thyroid extracts, obtained by ammonium sulfate precipitation, were separated by column fractionation into four Tg polypeptides, with apparent masses of 660, 330, 210, and 50 kDa. As assessed by enzyme-linked immunoadsorbent assays and ligand blot binding assays, megalin bound to intact Tg (660 and 330 kDa) and, to a even greater extent, to the 210-kDa Tg polypeptide. Furthermore, the 210-kDa Tg polypeptide inhibited megalin binding to intact Tg by ~70%. Solid phase assays showed binding of biotin-labeled heparin to intact Tg and to the 210-kDa Tg polypeptide. We characterized the 210-kDa Tg polypeptide by matrix-assisted laser desorption/ionization mass spectrometry analysis and found that it corresponds to the carboxyl-terminal portion of rat Tg. We developed a synthetic peptide corresponding to a 15-amino acid sequence in the carboxyl-terminal portion of rat Tg (Arg689-Lys703), containing a heparin-binding consensus sequence (SRRLKRP) and demonstrated heparin binding to this peptide. A rabbit antibody raised against the peptide recognized intact Tg in its native conformation and under denaturing conditions. This antibody markedly reduced heparin-binding to intact Tg, indicating that the region of native Tg corresponding to the peptide is involved in heparin binding. Furthermore, the anti-Tg peptide antibody almost completely inhibited binding of megalin to Tg, suggesting that the Tg region containing the peptide sequence is required for megalin binding. Physiologically, Tg binding to megalin on thyroid cells may be facilitated by Tg interaction with heparin-like molecules (heparan sulfate proteoglycans) via adjacent binding sites.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
A. M. Pilling, S. A. Jones, H. J. Endersby-Wood, N. A. M. Mccormack, and J. A. Turton
Expression of Thyroglobulin and Calcitonin in Spontaneous Thyroid Gland Tumors in the Han Wistar Rat
Toxicol Pathol, April 1, 2007; 35(3): 348 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Conte, A. Arcaro, D. D'Angelo, A. Gnata, G. Mamone, P. Ferranti, S. Formisano, and F. Gentile
A Single Chondroitin 6-Sulfate Oligosaccharide Unit at Ser-2730 of Human Thyroglobulin Enhances Hormone Formation and Limits Proteolytic Accessibility at the Carboxyl Terminus: POTENTIAL INSIGHTS INTO THYROID HOMEOSTASIS AND AUTOIMMUNITY
J. Biol. Chem., August 4, 2006; 281(31): 22200 - 22211.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Lisi, A. Pinchera, R. T. McCluskey, T. E. Willnow, S. Refetoff, C. Marcocci, P. Vitti, F. Menconi, L. Grasso, F. Luchetti, et al.
Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: A control mechanism for thyroid hormone release
PNAS, December 9, 2003; 100(25): 14858 - 14863.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Marino, L. Chiovato, S. Lisi, A. Pinchera, and R. T. McCluskey
Binding of the Low Density Lipoprotein Receptor-Associated Protein (RAP) to Thyroglobulin (Tg): Putative Role of RAP in the Tg Secretory Pathway
Mol. Endocrinol., October 1, 2001; 15(10): 1829 - 1837.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Marino and R. T. McCluskey
Role of thyroglobulin endocytic pathways in the control of thyroid hormone release
Am J Physiol Cell Physiol, November 1, 2000; 279(5): C1295 - C1306.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Duthoit, V. Estienne, F. Delom, J.-M. Durand-Gorde, B. Mallet, P. Carayon, and J. Ruf
Production of Immunoreactive Thyroglobulin C-Terminal Fragments during Thyroid Hormone Synthesis
Endocrinology, July 1, 2000; 141(7): 2518 - 2525.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Smith, N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, et al.
Conserved Surface-Exposed K/R-X-K/R Motifs and Net Positive Charge on Poxvirus Complement Control Proteins Serve as Putative Heparin Binding Sites and Contribute to Inhibition of Molecular Interactions with Human Endothelial Cells: a Novel Mechanism for Evasion of Host Defense
J. Virol., June 15, 2000; 74(12): 5659 - 5666.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.